Cravath’s London Office Moves to 100 Cheapside
On May 21, 2009, Chemed Corporation announced that it is in receipt of a letter from MMI Investments notifying Chemed’s Board of Directors that MMI is withdrawing its slate of nominees for election to Chemed’s Board at the 2009 Annual Meeting of Stockholders. On March 16, 2009, MMI notified Chemed that it would run a proxy contest for five seats on Chemed’s Board of Directors.
The lawyers involved include partners Allen Finkelson, Thomas E. Dunn and Andrew J. Pitts and associates Justin S. Tichauer, Leigh M. Harlan and Adrian James on corporate matters and associate Kerry Halpern-Skoglund on executive compensation and benefits matters.
Deals & Cases
November 15, 2024
Cravath represented the underwriters in connection with the $2.3 billion registered senior notes, floating rate senior notes and fixed-to-floating rate senior notes offering of State Street Corporation, a provider of a broad range of financial products and services to institutional investors worldwide. The transaction closed on October 22, 2024.
Deals & Cases
February 15, 2024
Cravath represented the underwriters in connection with the $750 million registered senior notes offering of KLA Corporation, a leading supplier of process control and yield management solutions for the semiconductor and related nanoelectronics industries. The transaction closed on February 1, 2024.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.